Epsilon Group Launches FDA-Approved Type 1 Diabetes Simulator

The Type 1 Diabetes Metabolic Simulator, based on technology licensed from the University of Virginia, is the first in silico tool to receive FDA approval as a substitute for preclinical animal testing of type 1 diabetes control strategies.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.